Search Results
Feb 24, 2026, 08:22 ET Notice of Presentation: Sivers Semiconductors to Present Q4 2025 Interim Results and Business Update
https://news.cision.com/sivers-semiconductors/r/notice-of-presentation--sivers-semiconductors-to-present-q4-2025-interim-results-and-business-update,c4312191
More news about: Sivers Semiconductors
Feb 24, 2026, 08:16 ET The Post-GenAI Era Starts Now: Quarrio Launches Deterministic AI for Enterprise Execution
www.quarrio.comReferencesChallapally, A., Pease, C., Raskar, R., & Chari, P. (2025, July). The GenAI divide: State of AI in business 2025 (Report). MIT NANDA (Project NANDA).Seetharaman, D., Mukherjee,
More news about: Quarrio
Feb 24, 2026, 08:15 ET Manulife | Comvest Credit Partners leads $130 million refinancing of Sylmar to support expansion strategy
services to utility and commercial customers across the United States. The Company's brand portfolio includes ProChem, EAI Water, Clearwater Industries, R2J Chemical Services, and Eastern Technologies Inc."Sylmar is a fast-growing leader in industrial water services, delivering critical solutions
More news about: Manulife Wealth & Asset Management
Feb 24, 2026, 08:14 ET Kennametal uruchamia globalny program „Machinist of the Year", aby uhonorować wieloletnich klientów i liderów branży
Kennametal.Harmonogram:luty 2026 r. - oficjalna inauguracja programuczerwiec 2026 r. - ogłoszenie regionalnych nominowanych i rozpoczęcie głosowaniawrzesień/październik 2026 r. - ogłoszenie regionalnych zwycięzców podczas targów oraz onlineAby
More news about: Kennametal Inc.
Feb 24, 2026, 08:08 ET Oklahoma Strengthens Food Processing Infrastructure with $7 Million Investment at Oklahoma State University, Installs Hiperbaric 55 HPP System
processors.With this installation, Oklahoma State University joins the Hiperbaric HPP Academia Network, a global consortium of universities, R&D centers and pilot facilities that provide multidisciplinary support for food innovation. Through the network, institutions collaborate on HPP testing
More news about: Hiperbaric
Feb 24, 2026, 08:01 ET START Appoints Dr. Frank Smith President of its XenoSTART Preclinical Research Business Unit
business unit. In this role, Dr. Smith will oversee XenoSTART's operations, further strengthen its project delivery and quality systems, and provide R&D leadership to scale the business and reinforce its position as a leading preclinical partner to oncology drug developers worldwide.
More news about: The START Center for Cancer Research
Feb 24, 2026, 08:00 ET The State Fair of Texas Extends Partnership with accesso® Through 2030, Embracing Innovation and Guest Convenience
operations, increase revenue and improve the guest journey. We deliver a high volume of product enhancements year-round and continuously invest in R&D to help venues and operators adapt to evolving guest needs.accesso is a public company, listed on AIM: a market operated by the London
More news about: accesso Technology Group
Feb 24, 2026, 08:00 ET The State Fair of Texas Extends Partnership with accesso® Through 2030, Embracing Innovation and Guest Convenience
operations, increase revenue and improve the guest journey. We deliver a high volume of product enhancements year-round and continuously invest in R&D to help venues and operators adapt to evolving guest needs.accesso is a public company, listed on AIM: a market operated by the London
More news about: accesso Technology Group
Feb 24, 2026, 08:00 ET LG BEGINS U.S. ROLLOUT OF ULTRAGEAR EVO G9, BUILT TO REDEFINE LARGE-SCREEN GAMING
ample space for multitasking, content creation, and immersive entertainment.Designed to align more naturally with the viewer's sightline, the 1000R curve enhances depth and visual continuity, keeping ultra-high-definition detail consistently sharp across the expansive screen.Immersive Visuals
More news about: LG Electronics USA
Feb 24, 2026, 08:00 ET Citius Pharmaceuticals, Inc. Secures $3.8 million through New Jersey Economic Development Program
biotechnology businesses with net operating losses to sell their unused net operating loss carryover (NOL) and unused research and development tax credits (R&D Tax Credits) for at least 80% of the value of the tax benefits to a profitable corporate taxpayer in the State of New Jersey that is not an affiliated
More news about: Citius Pharmaceuticals, Inc.
Feb 24, 2026, 08:00 ET Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide medicines), building on continued efforts to expand access
States, Novo Nordisk has a 40-year presence, is headquartered in New Jersey and employs approximately 10,000 people across more than 10 manufacturing, R&D, and corporate locations in eight states plus Washington, D.C. For more information, visit
More news about: NOVO NORDISK INC.
Feb 24, 2026, 07:30 ET BTQ Announces QPerfect and SDT Launch MIMIQ™-Powered Quantum Emulation Service on QUREKA™
design, test, and validate quantum algorithms at scales beyond today's hardware limits, helping research teams and enterprises accelerate quantum R&D and prepare workflows for next-generation processors.Go-live timeline and delivery model: SDT will operate and commercialize
More news about: BTQ Technologies Corp.
Feb 24, 2026, 07:13 ET TELUS Digital presenta la transformación de la IA en las telecomunicaciones en el Mobile World Congress 2026
[email protected] Preguntas frecuentes:P: ¿Qué presentará TELUS Digital en el Mobile World Congress (MWC) 2026 en Barcelona?R: TELUS Digital presentará sus capacidades de experiencia del cliente (CX) y transformación de IA para la industria de las telecomunicaciones, así como
More news about: TELUS Digital; TELUS Communications Inc.
Feb 24, 2026, 07:09 ET Einride has Divested its Design Organization
https://news.cision.com/einride/r/einride-has-divested-its-design-organization,c4311818The following files are available for download:
More news about: Einride
Feb 24, 2026, 07:02 ET Einride has Divested its Design Organization
https://news.cision.com/einride/r/einride-has-divested-its-design-organization,c4311818The following files are available for download:
More news about: Einride
Feb 24, 2026, 07:01 ET Iridium Launches Next Generation IoT Platform
(IMT®) for industrial-scale, larger payload capabilities with the Iridium Certus 9704The Iridium 9604, built on the u-blox SARA-R5 platform, delivers a compact 16 mm x 26 mm x 2.4 mm form factor, best for dual-mode IoT deployments previously cost-prohibitive across industrial, infrastructure,
More news about: Iridium Communications Inc.
Feb 24, 2026, 07:01 ET Iridium Launches Next Generation IoT Platform
(IMT®) for industrial-scale, larger payload capabilities with the Iridium Certus 9704The Iridium 9604, built on the u-blox SARA-R5 platform, delivers a compact 16 mm x 26 mm x 2.4 mm form factor, best for dual-mode IoT deployments previously cost-prohibitive across industrial, infrastructure,
More news about: Iridium Communications Inc.
Feb 24, 2026, 07:00 ET Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results
SegmentPain Management and Recovery ("PM&R") segment net sales for the fourth quarter of 2025 was $61.6 million, an increase of 1.3% compared to the prior year period.Operating income in the PM&R segment for the fourth quarter of 2025 was $5.2 million compared
More news about: Avanos Medical
Feb 24, 2026, 07:00 ET Main Street Announces Second Quarter 2026 Regular Monthly Dividends and Supplemental Dividend Payable in March 2026
CorporationDwayne L. Hyzak, CEO, [email protected] R. Nelson, CFO, [email protected]
More news about: Main Street Capital Corporation
Feb 24, 2026, 06:57 ET Valmet has published the Annual Report, the Corporate Governance Statement and the Remuneration Report for 2025
https://news.cision.com/valmet-oyj/r/valmet-has-published-the-annual-report--the-corporate-governance-statement-and-the-remuneration-repo,c4312094The following files are available for download:
More news about: Valmet Oyj
Feb 24, 2026, 06:40 ET BRIGHTSTAR LOTTERY PLC REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
growth and OPtiMa savings more than offset approximately $50 million of investments in growth initiatives such as Italy B2C and iLottery expansion; R&D for technology products and services; and project costs associated with the extensive contract renewal cycle recently completedNet cash used
More news about: Brightstar Lottery PLC
Feb 24, 2026, 06:27 ET Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results
contributing to next wave innovation pipeline: monoclonal antibody discovery and immuno-therapeuticsAnnounced intended closure of German animal R&D facility and targeted reduction to manufacturing workforce along with increased investment in Elanco Innovation Laboratories at Indiana headquarters
More news about: Elanco Animal Health
Feb 24, 2026, 06:02 ET Frontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics
Biotech, stated:"We are excited to establish the agreement with GSK, a global biopharma company. It reflects the growing recognition of our R&D capabilities. This agreement will solidify a robust foundation for Frontier Biotech by deepening international collaborations, accelerating pipeline
More news about: Frontier Biotechnologies Inc.
Feb 24, 2026, 06:00 ET China Yuchai International Announces Unaudited 2025 Second Half-Year and Full Year Financial Results
development ("R&D") expenses increased by 48.0% to RMB 874.9 million (US$ 124.5 million), compared with RMB 591.1 million in 2H 2024, mainly driven by higher experimental costs, increased personnel expenses, higher mold costs, and impairments related to fuel cell development. Total R&D expenditure,
More news about: China Yuchai International
Feb 24, 2026, 05:55 ET Frontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics
Biotech, stated:"We are excited to establish the agreement with GSK, a global biopharma company. It reflects the growing recognition of our R&D capabilities. This agreement will solidify a robust foundation for Frontier Biotech by deepening international collaborations, accelerating pipeline
More news about: Frontier Biotechnologies Inc.